Moreover, elevated FTO and YTHDF1 in astrocytes induce mitochondrial dysfunction and oxidative stress, which can be mitigated by the FTO inhibitor MO-I-500 in AD [108] (Figure 3). The gene discussed is FTO; the disease is Alzheimer disease.